Indole derivatives as steroid 5 alpha-reductase inhibitors
CA 2117610 C · Owner: Pfizer Limited · Inventors: Blagg, Julian; Greengrass, Colin William; Finn, Paul William
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides compounds of formula (I) and the pharmaceutically acceptable salts thereof wherein X is, O, NH, N(C1-C4 alkyl), direct link C1-C4 alkylene, C2-C4 alkenylene or C2-C4 alkynylene said alkylene, alkenylene and, alkynylene being optionally substituted by C1-C4 alkyl or aryl; Y is methylene C2-C6 alkylene optionally interrupted by O C2-C6 alkenylene or C2-C6 alkynylene, all of which may be optionally substituted by C1-C6 alkyl or is a group of formula, (II) wherein m and n are each independently selected from O and an integer of from 1 to 5 with the proviso that the sum of, m and n is not greater than 5 and p is an integer of from 2 to 6; R is H OH, halo, C1-C4 …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 16, 1993 and granted July 18, 2000. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended February 16, 2013.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 16, 2015.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.